Role of tumor markers in patients with solid cancers: A critical review.
about
Considering Exosomal miR-21 as a Biomarker for CancerRecent advances in clinical applications of circulating cell-free DNA integritySystemic mirnas as potential biomarkers for malignancyCancer stem cells: the lessons from pre-cancerous stem cellsLung cancer epigenetics: emerging biomarkersAdvanced proteomic technologies for cancer biomarker discovery.Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcomaPiwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarkerY-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease.At which stage of gastric cancer progression do levels of carcinoembryonic antigen and carbohydrate antigen 19-9 increase? Application in advanced gastric cancer treatment.Detection of serum tumor markers in multiple myeloma using the CLINPROT system.Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles.Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer.Diagnostic value of microRNA-21 in the diagnosis of lung cancer: evidence from a meta-analysis involving 11 studies.MiR-16 family as potential diagnostic biomarkers for cancer: a systematic review and meta-analysisThe expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers.Downregulation of MiR-30a is Associated with Poor Prognosis in Lung CancerSerum microRNAs as biomarkers for recurrence in melanoma.Fine-scale quantification of HCG beta gene transcription in human trophoblastic and non-malignant non-trophoblastic tissues.A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.Molecular pathology of pancreatic cancer: from bench-to-bedside translation.Tumor markers in clinical practice: a review focusing on common solid cancersSerum tumor markers and PET/CT imaging for tumor recurrence detection.Bioinformatics advances for clinical biomarker development.Dipeptidyl peptidase-IV and related molecules: markers of malignancy?Design of immunoprobes for electrochemical multiplexed tumor marker detection.Diagnostic significance of circulating multiple miRNAs in breast cancer: a systematic review and meta-analysis.Circulating miR-34a levels are reduced in colorectal cancer.Dispersion of single-wall carbon nanotubes with supramolecular Congo red - properties of the complexes and mechanism of the interaction.Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions.Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma.Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis.
P2860
Q26752550-BF87E82F-9674-4290-9366-63B7C9B21834Q26861681-F2D068D7-8588-4AF5-95A7-E198B30C3669Q27004655-C05895D3-390E-4A90-B6CA-A2B651D9B44FQ28259527-BCA66E69-BCC7-4987-AB5A-414B112953C4Q28285049-53A52B7E-AB04-494C-B240-22D87220A390Q33433660-8444754F-40AF-4501-B91D-F6A25906373DQ33775228-2142EBD0-721C-4893-B3EC-2A80AA399CABQ33861066-00E9EF49-EEBF-4C85-AE4E-5DECC95281E9Q33906226-CBB0D62F-D9BA-4DEC-A380-01A7E31E19FAQ33927576-B84D4924-19B0-4DD6-863D-0CECAB108EF7Q34249148-FB2A444F-2E0A-4F52-B82C-06B50F92F210Q34535929-A84A7064-EA51-4EA1-8C01-42D2CFCD4D9EQ34559564-0AC8D56A-6730-4D78-B4B1-5503E9F35682Q34689736-68FD548C-1FF7-4811-BBDB-C81121ABFF22Q35177139-7B69B5C9-B886-4A5A-84FB-43DBF3D310B0Q35479266-7A59925D-A674-414B-8870-BBF607DD8EB7Q35482100-C7FAA659-612E-4265-BC39-4F34661F591CQ36010194-583E7468-5D30-41D3-95CC-7D68795F0845Q36341127-0D410CDF-4948-4BA8-874C-1C7ADDA6B9DBQ37065768-D2205547-70CB-4EFD-A904-87D05A4F8912Q37641977-497CD99E-1435-4E33-9F74-3843FA3EE213Q37998096-5BDF2D5E-A110-4C64-B7D0-BBC9D2B749F7Q38010046-80B4EB43-FF53-4235-9B4E-B0C22551FC03Q38082682-5E400EF6-A2EC-4654-92F2-88E452A830CCQ38088378-62F8AA32-814E-4810-AEC7-33BE2B38C158Q38089765-D040864B-49F7-430C-9005-C25C4CA3EA3FQ38509300-6537798E-F66F-47D5-854A-44F9E77C8F00Q38845874-4970C3E1-6C66-43EE-89E8-ECB62BA47191Q39610241-EA6DC427-8562-4F6B-BF7B-C1F296E0EFCBQ42046991-CAFD37C7-1AD7-45F6-8BF7-D8093F723E07Q43244893-EA7B423D-9E0A-4557-A51C-3C2A65EE0752Q47110506-D73B47F6-839C-4B84-8823-1A08C6D5B26EQ51854381-35D51924-E7FD-499B-A505-C3E12C6657FFQ52859395-D2974536-4E1D-414B-8B85-4A824AA265C4
P2860
Role of tumor markers in patients with solid cancers: A critical review.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Role of tumor markers in patients with solid cancers: A critical review.
@en
type
label
Role of tumor markers in patients with solid cancers: A critical review.
@en
prefLabel
Role of tumor markers in patients with solid cancers: A critical review.
@en
P1476
Role of tumor markers in patients with solid cancers: A critical review.
@en
P2093
Michael J Duffy
P304
P356
10.1016/J.EJIM.2006.12.001
P577
2007-05-01T00:00:00Z